'Pcr rate' presentation slideshows

ASCO Update 2012: Gastrointestinal Malignancies

897 views • 68 slides

Neo-adjuvant Chemotherapy for Breast Cancer

Neo-adjuvant Chemotherapy for Breast Cancer. Shiuh-Wen Luoh MD PhD Portland VA Medical Center Oregon Health Sciences University. Neoadjuvant Treatment of Primary BC Improve Surgical Options Obtain Information on Response Obtain Long Term Disease Free Control. JCO Vol 24, pp 1940-, 2006.

955 views • 61 slides

Inflammatory Breast Cancer

Inflammatory Breast Cancer. Julie Lang, MD Assistant Professor of Surgery Director of Breast Surgical Oncology University of Arizona Cancer Center. Inflammatory Breast Cancer. Rare, represents <6% of all breast cancers Most aggressive form of breast cancer Clinical diagnosis

1.07k views • 48 slides

DEPARTMENT OF ONCOLOGY AND HEMATOLOGY UNIVERSITY OF MODENA AND REGGIO EMILIA MODENA, ITALY

522 views • 28 slides

Terapia Neoadiuvante Revisione delle evidenze scientifiche

Terapia Neoadiuvante Revisione delle evidenze scientifiche. Valentina Guarneri Nonantola, 19 Novembre 2011. Preoperative vs postoperative, Overall Survival. DDFS o OS???. The Cochrane Library, Issue 3, 2008. pCR vs residual disease, Overall Survival. The Cochrane Library, Issue 3, 2008.

412 views • 27 slides

Terapia Neoadiuvante Revisione delle evidenze scientifiche

Terapia Neoadiuvante Revisione delle evidenze scientifiche. Valentina Guarneri Nonantola, 19 Novembre 2011. Preoperative vs postoperative, Overall Survival. DDFS o OS???. The Cochrane Library, Issue 3, 2008. pCR vs residual disease, Overall Survival. The Cochrane Library, Issue 3, 2008.

415 views • 27 slides

What can Xeloda add to neoadjuvant chemotherapy?

What can Xeloda add to neoadjuvant chemotherapy?. Marjorie Green MD Anderson Cancer Center University of Texas Texas, USA. Rationale for integrating Xeloda into the treatment of early BC. Highly effective in metastatic BC Favorable safety profile minimal myelosuppression and alopecia

456 views • 17 slides

Gianni L et al. Proc SABCS 2010 ; Abstract S3-2.

324 views • 13 slides